Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1990 2
1993 1
1994 2
1995 2
1996 1
1997 3
1998 1
1999 1
2001 3
2002 1
2004 2
2005 4
2006 5
2007 2
2008 3
2009 1
2011 2
2012 1
2015 4
2016 3
2017 5
2018 2
2021 1
2022 1
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment.
Molas ME, Knobel H, Ferrández O, de Antonio Cuscó M, Carballo Martínez N, Rodríguez Caba C, Luque S, Guelar A, Castañeda Espinosa S, Grau S. Molas ME, et al. Among authors: guelar a. Rev Esp Quimioter. 2022 Feb;35(1):71-75. doi: 10.37201/req/055.2021. Epub 2021 Nov 26. Rev Esp Quimioter. 2022. PMID: 34823348 Free PMC article.
Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine.
Güerri-Fernández R, Molina-Morant D, Villar-García J, Herrera S, González-Mena A, Guelar A, Trenchs-Rodríguez M, Díez-Pérez A, Knobel H. Güerri-Fernández R, et al. Among authors: guelar a. J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):322-327. doi: 10.1097/QAI.0000000000001396. J Acquir Immune Defic Syndr. 2017. PMID: 28418990
Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
Mallolas J, Blanco J, Labarga P, Vergara A, Ocampo A, Sarasa M, Arnedo M, López-Púa Y, García J, Juega J, Guelar A, Terrón A, Dalmau D, García I, Zárraga M, Martínez E, Carné X, Pumarola T, Escayola R, Gatell J. Mallolas J, et al. Among authors: guelar a. HIV Med. 2007 May;8(4):226-33. doi: 10.1111/j.1468-1293.2007.00464.x. HIV Med. 2007. PMID: 17461850 Free article. Clinical Trial.
54 results